Literature DB >> 177189

Wilms' tumor: natural history and prognostic factors: a retrospective study of 248 cases treated at the Institut Gustave-Roussy 1952-1967.

J Lemerle, M F Tournade, R G Marchant, R Flamant, D Sarrazin, F Flamant, M Lemerle, S Jundt, J M Zucker, O Schweisguth.   

Abstract

A statistical analysis of 248 histologically proven cases of Wilms' tumor treated at the Institut Gustave-Roussy, Villejuif, France, from 1952 to 1967, is presented. Two years recurrence-free survival and five years survival have been selected as prognostic criteria. Patients under two years of age have significantly fewer metastases and a better five-year survival rate than those over two. Stage is stronly correlated with recurrences and survival. Influence of tumor size, number of tumor nodules, tumor rupture, adhesions, regional lymph node involvement, and renal vein infiltration is shown. Detailed analysis of histopathologic features indicates that a favorable clinical course is significantly related to the number of different varieties of epithelial differentiation (tubular, glomerular, microcystic) found in any tumor, whatever the abundance of each of them. Presence of striated muscular cells, however abundant, does not influence survival or metastatic rates. Cases where irradiation given prior to surgery resulted in complete destruction of tumor cells, form a distinctive group of very unfavorable prognosis. Relapse of tumor occurs in 54% of cases, 10% presenting with metastases. Involved sites are listed. No correlation is found between date of metastases and other parameters. The three major prognostic factors of age, stage, histologic pattern, bear prognostic value separately. Stage and age are linked, as well as histology and age. Stage and histology are not linked. Age in itself therefore seems less important. It is concluded that these well-defining treatment for each individual case.

Entities:  

Mesh:

Year:  1976        PMID: 177189     DOI: 10.1002/1097-0142(197605)37:5<2557::aid-cncr2820370549>3.0.co;2-l

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  The surgical treatment of Wilms' tumor: results of the National Wilms' Tumor Study.

Authors:  L L Leape; N E Breslow; H C Bishop
Journal:  Ann Surg       Date:  1978-04       Impact factor: 12.969

2.  Cornelia de Lange syndrome associated with Wilms' tumour and infantile haemangioendothelioma of the liver: report of two autopsy cases.

Authors:  M Maruiwa; Y Nakamura; K Motomura; T Murakami; M Kojiro; M Kato; M Morimatsu; S Fukuda; T Hashimoto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

3.  Nephroblastoma and neuroblastoma--histology and prognosis.

Authors:  P Meister; M Middeke; H K Selbmann
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-10-30

4.  Bone metastases in children presenting with renal tumours.

Authors:  W Lawler; H B Marsden
Journal:  J Clin Pathol       Date:  1979-06       Impact factor: 3.411

5.  Association of Wilms' tumor and intracranial hemorrhage due to arteriovenous malformation.

Authors:  G Rosenn; J Maytal; G Lantos
Journal:  Childs Nerv Syst       Date:  1994-03       Impact factor: 1.475

6.  Nephroblastoma in infants, 1969-75: variations in treatment and survival.

Authors:  C A Stiller; E L Lennox
Journal:  Br Med J       Date:  1980-11-08

7.  Echographic aspects of hepatic metastases of nephroblastomas.

Authors:  D Filiatrault; L Garel; M F Tournade; J M Zucker
Journal:  Pediatr Radiol       Date:  1982

8.  Wilms' tumor metastatic to the mediastinum.

Authors:  H L Magill; J P Sackler; L S Parvey
Journal:  Pediatr Radiol       Date:  1982

9.  [Recurrence of Wilm's tumor following a 9-year disease-free interval].

Authors:  N Göldel; U Jehn; B Naujokat; W Permanetter
Journal:  Klin Wochenschr       Date:  1988-05-02

10.  The in vitro growth and characterization of the skeletal muscle component of Wilms' tumor.

Authors:  A J Garvin; F Surrette; D S Hintz; M T Rudisill; M A Sens; D A Sens
Journal:  Am J Pathol       Date:  1985-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.